Can the AstraZeneca share price continue to smash the FTSE 100?

G A Chester discusses the valuation and prospects of FTSE 100 (INDEXFTSE:UKX) pharma stock AstraZeneca plc (LON:AZN).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The AstraZeneca (LSE: AZN) share price has been making new all-time highs in recent weeks. It’s up 21% year to date, compared with a 9% decline for the FTSE 100. And over the past five years it’s climbed 87% versus a 5% gain for the index. Do I think it can continue to smash the market?

Historically low base

The company released its Q3 results earlier this month, and chief executive Pascal Soriot told investors: “Today marks an important day for the future of AstraZeneca, with the performance in the quarter and year to date showing what we expect will be the start of a period of sustained growth for years to come.”

This growth would start from a historically low base. Over the last 12 months, the company generated $399m net cash from operations on revenue of $21.5bn. There was a time when it was generating in excess of $10bn cash a year. This last occurred in 2010 when it posted $10.7bn (on revenue of $33.3bn). After investing activities and dividends, it still had more than $1bn left to add to its cash pile. Net cash at the year-end stood at $3.7bn.

Should you invest £1,000 in Diageo right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Diageo made the list?

See the 6 stocks

Roll on to 2013 when new boss Soriot delivered his first annual results, and the picture was already looking less rosy. Revenue had declined to $25.7bn, net cash from operations to $7.4bn and year-end net cash was just £39m. The table below shows some key numbers that illustrate the business’s continuing decline to where it is today.

  2014 2015 2016 2017 2018 (ytd) Total
Revenue ($bn) 26.1 24.7 23.0 22.5 15.7 112.0
Net cash inflow from operating activities ($bn) 7.1 3.3 4.1 3.6 0.4 18.5
Net cash inflow/(outflow) from investing activities (7.0) (4.2) (4.0) (2.3) 0.0 (17.5)
Dividends paid (£bn) (3.5) (3.5) (3.6) (3.5) (3.5) (17.6)

As you can see, revenue has fallen every year and net cash generated from operating activities has been a far cry from its heyday. Almost all the total of $18.5bn generated in the period has been ploughed back into investing activities ($17.5bn). This means that the business itself has supported just $1bn of the total of $17.6bn paid out in dividends. The company has simply been borrowing money and handing it over to shareholders. It’s gone from a net cash position of £39m at the start of 2014 to a net debt position of $16.2bn today.

Premium valuation

The impact of patent expiries on some of AstraZeneca’s key blockbuster drugs is now bottoming out. With new drugs coming through, the company is in a position to begin growing its top line again. However, it’s going to be quite some years before we see a return to anything like the aforementioned $33.3bn revenue and $10.7bn net cash generation we saw in 2010. As such, and with the company also having moved from a net cash position of $3.7bn in 2010 to that net debt of $16.2bn today, it seems strange to me that the shares have risen quite as far as they have. Indeed, the current price of 6,204p is more than double what it was when the company posted those impressive 2010 results.

The valuation today is 23.9 times current-year forecast earnings, falling to a still premium 21.6 next year on forecasts of 10.3% earnings growth. The price-to-earnings growth (PEG) ratio of 2.1 is well above the PEG ‘fair value’ marker of 1, while the dividend yields a below-market-average 3.5% and will need more borrowing to fund it in the near term. I believe the current valuation is too rich, so I’m avoiding the stock at this stage.

Should you invest £1,000 in Diageo right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Diageo made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Pound coins for sale — 51 pence?

This seems ridiculous, but we almost never see shares looking this cheap. Yet this recent ‘Best Buy Now’ has a price/book ratio of 0.51. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 51p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 8.5%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

More on Investing Articles

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

3 world-class investments to consider for a Stocks & Shares ISA while they’re on sale

Dr James Fox believes the current stock market volatility may provide some investors with the opportunity to supercharge their Stocks…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

The 2025 stock market sell-off could be a rare opportunity for second income investors

Millions of Britons invest for a second income and many will be asking whether the current market conditions are a…

Read more »

New year resolutions 2025 on desk. 2025 resolutions list with notebook, coffee cup on table.
Investing Articles

The stock market in 2025 could be a once-in-a-decade opportunity to build wealth in an ISA

This writer sees further volatility ahead in the stock market, which should create lucrative opportunities for ISA investors.

Read more »

Google office headquarters
Investing Articles

$1bn a day! This S&P 500 share still looks like a stock market bargain after Q1 earnings

The owner of Google and YouTube just announced strong results to the stock market, including another massive $70bn share buyback.

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

3 cheap FTSE 100 stocks with big dividends to consider buying right now

Sector weakness in some FTSE 100 industries has also left some of my long-term favourite stocks offering attractive dividend yields.

Read more »

Diverse children studying outdoors
Growth Shares

Forecast: £1,000 invested in Rolls-Royce shares could be worth this much by next year

Jon Smith talks through both his opinion and analysts’ forecasts when trying to predict where Rolls-Royce shares could head from…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

£5,000 invested in Lloyds shares 5 years ago is now worth…

The price of Lloyds shares has more than doubled over the past five years. However, our writer’s cautious about the…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Up 58% in a year, the BT share price could be the FTSE 100 target to beat in 2025

The BT share price has been steadily climbing back since newish boss Allison Kirkby came on board. Is the new…

Read more »